Chronic Myeloproliferative Disorders
Showing NaN - NaN of 7
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in United States (fenretinide)
Completed
- Chronic Myeloproliferative Disorders
- +3 more
-
Los Angeles, California
- +3 more
Jul 18, 2017
Chronic Myeloproliferative Disorders
Completed
- Polycythemia Vera
- +4 more
-
Washington, D.C., District of Columbia
- +1 more
Jun 30, 2017
Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in United States (ruxolitinib phosphate, laboratory biomarker
Completed
- Chronic Myeloproliferative Disorders
- +4 more
- ruxolitinib phosphate
- +2 more
-
Birmingham, Alabama
- +23 more
Oct 22, 2014
Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic/Myeloproliferative Diseases Trial run by the NHLBI
Terminated
- Chronic Myeloproliferative Disorders
- +2 more
- cyclophosphamide
- +15 more
-
Bethesda, MarylandNIH - Warren Grant Magnuson Clinical Center
Apr 30, 2013
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial run by the CC (tanespimycin)
Completed
- Chronic Myeloproliferative Disorders
- +4 more
-
Bethesda, Maryland
- +1 more
Mar 14, 2012
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial run by the CC (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +5 more
- filgrastim
- +12 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
Mar 7, 2012
Breast Cancer, Chronic Myeloproliferative Disorders, GTD Trial run by the CC (ravuconazole)
Completed
- Breast Cancer
- +11 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Mar 7, 2012